PE/Packard BioScience Merger Targets Growing Biochip/Microarray Market
This article was originally published in The Gray Sheet
Executive Summary
Perkin Elmer will bolster its proteomics and genomics business by adding liquid handling and automated sample preparation systems to its instrumentation and reagent offerings through the $650 mil. acquisition of Packard BioScience, announced July 15.